Peter MacCallum Cancer Centre
Peter MacCallum Cancer Centre
Parkville, Victoria, Australia2 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Trial of Glioblastoma Immunotherapy Advancement With Nivolumab and Relatlimab | Newly Diagnosed Glioblastoma | Recruiting | Phase 2 | 2026-09-17 | NCT06816927 | |
| Genetically Risk-Stratified Venetoclax, Ibrutinib, Rituximab (± Navitoclax) in Relapsed/Refractory Mantle Cell Lymphoma | Mantle Cell Lymphoma Refractory | Active, not recruiting | Phase 2 | 2024-08-12 | NCT05864742 |